Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Reserpine binding to a vesicular amine transporter expressed in Chinese hamster ovary fibroblasts.

Schuldiner S, Liu Y, Edwards RH.

J Biol Chem. 1993 Jan 5;268(1):29-34.

2.
3.

Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.

Henry JP, Botton D, Sagne C, Isambert MF, Desnos C, Blanchard V, Raisman-Vozari R, Krejci E, Massoulie J, Gasnier B.

J Exp Biol. 1994 Nov;196:251-62. Review.

4.

[Molecular pharmacology of the catecholamine transporter of chromaffin granules from the bovine adrenal medulla].

Henry JP, Scherman D, Roisin MP, Gasnier B, Isambert MF.

Biochimie. 1986 Mar;68(3):451-8. Review. French.

PMID:
3017452
5.

Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter.

Rudnick G, Steiner-Mordoch SS, Fishkes H, Stern-Bach Y, Schuldiner S.

Biochemistry. 1990 Jan 23;29(3):603-8.

PMID:
2140052
8.

The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules.

Sagné C, Isambert MF, Vandekerckhove J, Henry JP, Gasnier B.

Biochemistry. 1997 Mar 18;36(11):3345-52.

PMID:
9116013
9.

Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.

Schuldiner S, Steiner-Mordoch S, Yelin R, Wall SC, Rudnick G.

Mol Pharmacol. 1993 Dec;44(6):1227-31.

PMID:
7903417
10.

Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules.

Howell M, Shirvan A, Stern-Bach Y, Steiner-Mordoch S, Strasser JE, Dean GE, Schuldiner S.

FEBS Lett. 1994 Jan 24;338(1):16-22.

11.
12.

Expression cloning of a reserpine-sensitive vesicular monoamine transporter.

Erickson JD, Eiden LE, Hoffman BJ.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10993-7.

13.

Identification of a novel, inhibitory action of amiodarone on vesicular monoamine transport.

Haikerwal D, Dart AM, Little PJ, Kaye DM.

J Pharmacol Exp Ther. 1999 Feb;288(2):834-7.

14.

Identification and purification of a functional amine transporter from bovine chromaffin granules.

Stern-Bach Y, Greenberg-Ofrath N, Flechner I, Schuldiner S.

J Biol Chem. 1990 Mar 5;265(7):3961-6.

15.

Expression and regulation of the bovine vesicular monoamine transporter gene.

Krejci E, Gasnier B, Botton D, Isambert MF, Sagné C, Gagnon J, Massoulié J, Henry JP.

FEBS Lett. 1993 Nov 29;335(1):27-32.

16.

The vesicular monoamine transporter: from chromaffin granule to brain.

Henry JP, Sagné C, Bedet C, Gasnier B.

Neurochem Int. 1998 Mar;32(3):227-46. Review.

PMID:
9587917
17.

Inhibition of norepinephrine transport and reserpine binding by reserpine derivatives.

Parti R, Ozkan ED, Harnadek GJ, Njus D.

J Neurochem. 1987 Mar;48(3):949-53.

PMID:
3806108
18.

Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.

Darchen F, Scherman D, Laduron PM, Henry JP.

Mol Pharmacol. 1988 Jun;33(6):672-7.

PMID:
3380081
19.
20.

Hydrophobicity of the tetrabenazine-binding site of the chromaffin granule monoamine transporter.

Scherman D, Gasnier B, Jaudon P, Henry JP.

Mol Pharmacol. 1988 Jan;33(1):72-7.

PMID:
3336349

Supplemental Content

Support Center